title: Deaths in trials should always be reported.
authors.affiliation: js@cochrane.dk
authors.forename: Jeppe
authors.initials: J
authors.lastname: Schroll
mesh_terms: D002219:Carbamates / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000592:standards*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects; D009026:Mortality; D010880:Piperidines / Q000009:adverse effects / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000009:adverse effects
chemical_list: D002219:Carbamates; D007004:Hypoglycemic Agents; D010880:Piperidines; D013453:Sulfonylurea Compounds; C072379:repaglinide